Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren K Patten

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cureus|December 6, 2021
Reverse Abdominoplasty: A Novel Practical Approach Using Oncoplastic Reconstruction in Managing Major Chest Wall Defects for Patients With Loco-Regional Recurrence Following Breast Cancer SurgeryFiori Teklebrhan, Gheed Mahir, Stephanie Clark, et al.
Breast (Edinburgh, Scotland)|June 23, 2012
Is the presence of small volume disease in the sentinel node an indication for axillary clearance?Darren K Patten, Daniel R Leff, Zubair Wani, et al.
Plastic and Reconstructive Surgery. Global Open|October 24, 2015
Trends in Immediate Postmastectomy Breast Reconstruction in the United KingdomDaniel R Leff, Alex Bottle, Erik Mayer, et al.
Breast Cancer Research and Treatment|May 1, 2007
Diffuse optical imaging of the healthy and diseased breast: a systematic reviewDaniel Richard Leff, Oliver J Warren, Louise C Enfield, et al.
Cancer Research|January 18, 2018
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial DiagnosisEdward Curry, Constanze Zeller, Nahal Masrour, et al.
Oncotarget|June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationMonica Faronato, Van T M Nguyen, Darren K Patten, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cureus|December 6, 2021
Reverse Abdominoplasty: A Novel Practical Approach Using Oncoplastic Reconstruction in Managing Major Chest Wall Defects for Patients With Loco-Regional Recurrence Following Breast Cancer SurgeryFiori Teklebrhan, Gheed Mahir, Stephanie Clark, et al.
Breast (Edinburgh, Scotland)|June 23, 2012
Is the presence of small volume disease in the sentinel node an indication for axillary clearance?Darren K Patten, Daniel R Leff, Zubair Wani, et al.
Plastic and Reconstructive Surgery. Global Open|October 24, 2015
Trends in Immediate Postmastectomy Breast Reconstruction in the United KingdomDaniel R Leff, Alex Bottle, Erik Mayer, et al.
Breast Cancer Research and Treatment|May 1, 2007
Diffuse optical imaging of the healthy and diseased breast: a systematic reviewDaniel Richard Leff, Oliver J Warren, Louise C Enfield, et al.
Cancer Research|January 18, 2018
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial DiagnosisEdward Curry, Constanze Zeller, Nahal Masrour, et al.
Oncotarget|June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationMonica Faronato, Van T M Nguyen, Darren K Patten, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
Pageof 2